Director/PDMR Shareholding

RNS Number : 9402R

GlaxoSmithKline PLC

05 March 2019

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr B McNamara
b)	Position/status	CEO, GSK Consumer Healthcare
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	Cash payout of £270,644.71 less applicable tax withholding in respect of 6,700.785 notional ADS following vesting of an award made on 2 March 2015 under the GlaxoSmithKline Deferred Investment Award plan.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$40.39	6,700.785
d)	Aggregated information	n/a (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2019-03-04
f)	Place of the transaction	n/a

 

END

 

 

DSHDELFBKXFFBBD